Introduction
============

Gastric carcinoma (GC) is the third most common malignancy worldwide with approximately 1.3 million newly diagnosed cases.[@b1-cmar-10-2605] In People's Republic of China, GC ranks as the second most frequently occurring cancer and cause of cancer deaths; approximately 679,100 new cases and 498,000 GC-related deaths were projected to occur in 2015.[@b2-cmar-10-2605] The prognosis of GC differs significantly in accordance with various stages; the 5-year overall survival rate of early GC is over 90%, while that of advanced GC is about 15%.[@b3-cmar-10-2605] Early diagnosis and treatment of GC could contribute to the prolonged survival of GC patients.[@b4-cmar-10-2605]

Gastric intraepithelial neoplasia (GIN) is well accepted as a precancerous lesion of GC, which can be divided into 2 categories according to lesion location: proximal and distal intraepithelial neoplasia (PGIN and DGIN, respectively).[@b5-cmar-10-2605] The annual incidence of GC is 6% for high-grade GIN patients within 5 years after diagnosis.[@b6-cmar-10-2605] To date, numerous efforts have been devoted to identify the clinical and epidemiological features of GC;[@b7-cmar-10-2605],[@b8-cmar-10-2605] however, GIN remains poorly understood. Furthermore, previous studies demonstrated that proximal and distal GC (PGC and DGC) are 2 distinct entities with different epidemiologic, clinicopathologic, and molecular biological features.[@b9-cmar-10-2605]--[@b11-cmar-10-2605] Hence, it is of vital importance to explore the potential variety between risk factors for PGIN and DGIN.

In the current study, we retrospectively enrolled 485 GIN patients to provide a comprehensive overview of the clinical and pathological features of GIN. Furthermore, 310 age- and gender-matched healthy volunteers were recruited for comparison to identify the potential risk factors for GIN.

Patients and methods
====================

Patient selection
-----------------

From January 2007 to December 2014, 630 consecutive patients who underwent endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) for GIN at Nanjing Drum Tower Hospital were initially included in the current study. The inclusion criteria were set as follows: 1) age ≥18 years and 2) pathologically diagnosed with GIN after ESD/EMR by 2 independent experienced pathologists. The exclusion criteria were as follows: 1) pathologically diagnosed with GC after operation, 2) multifocal lesion which was defined as the distance between 2 lesions over 20 mm, 3) a history of GC, and 4) tumor located at distal esophagus and gastroesophageal junction. The detailed selection criteria are demonstrated in [Figure 1](#f1-cmar-10-2605){ref-type="fig"}. A total of 485 patients with GIN were finally enrolled in this study. Furthermore, 310 gender- and age-matched outpatients who underwent endoscopy and biopsy confirmed to be negative for GC or GIN were recruited as the control group. The study protocol was approved by the institutional review board of Nanjing Drum Tower Hospital, and written informed consent was obtained from all individual participants.

Study procedure
---------------

All endoscopy procedures including ESD/EMR were performed by well-trained physicians. The endoscopic morphology of superficial lesions was recoded according to the Paris classification system.[@b12-cmar-10-2605] The representative histologic images of low- and high-grade GIN are shown in [Figure 2A and B](#f2-cmar-10-2605){ref-type="fig"}, respectively. Furthermore, the GIN lesions were categorized into 2 groups: PGIN, which was defined as a lesion located within 30 mm from the gastroesophageal junction and DGIN, which was described as a lesion located in the remaining regions. The electronic medical records were thoroughly reviewed, and clinical follow-up was performed by office visit or telephone contact. Information, including history of cancer, personal history, dietary habit, and present relevant diseases, were collected in a uniform form as was previously reported.[@b13-cmar-10-2605] [Table S1](#SD1-cmar-10-2605){ref-type="supplementary-material"} presents the detailed items and corresponding definitions.

Statistical analysis
--------------------

The continuous variables are presented as mean ± SD after the confirmation of normal distribution and were compared using Student's *t*-test or 1-way analysis of variance test. The categorical variables are presented as counts and percentages and compared with χ^2^ statistics or Fisher's exact test when appropriate. To identify the potential risk factors, the univariate and multivariate logistic regression analyses were applied and are presented as odds ratio (OR) with the corresponding 95% confidential interval (95% CI). The statistical analyses were performed using SPSS (version 22.0; IBM Corporation, Armonk, NY, USA), and statistical significance was taken as a 2-sided *P*-value \<0.05.

Results
=======

Baseline clinical and pathological characteristics
--------------------------------------------------

A total of 485 GIN patients were enrolled in this study. Among these participants, 156 were diagnosed with PGIN ([Figure 2C](#f2-cmar-10-2605){ref-type="fig"}). The proportion of incident PGIN cases increased gradually from 13.6% in 2007--2008 to 35.3% in 2012--2014 ([Figure 2D](#f2-cmar-10-2605){ref-type="fig"}). The mean age was 62.3 years and differed between 2 groups (PGIN vs DGIN: 63.8±8.5 vs 61.6±9.4 years, *P*=0.018; [Table 1](#t1-cmar-10-2605){ref-type="table"}). As summarized in [Table 1](#t1-cmar-10-2605){ref-type="table"}, significant differences were observed in the distributions of age, gender, endoscopic morphology, histologic grade, occurrence of gastritis cystica profunda, and pancreatic metaplasia between PGIN and DGIN patients. During the follow-up period, 51 (10.5%) were patients lost to followup, and the remaining 434 GIN patients with 310 age- and gender-matched healthy controls were included in the comparative analyses ([Figure 1](#f1-cmar-10-2605){ref-type="fig"}).

Comparison of risk factors for GIN and subgroup analyses stratified by PGIN and DGIN
------------------------------------------------------------------------------------

Compared to the control group, family cancer history (FCH); alcohol abuse; tobacco abuse; intake of high sodium, preserved food, spicy food, less fruit; *Helicobacter pylori* (Hp) infection, and atrophic gastritis with intestinal metaplasia were more frequent in GIN patients ([Table 2](#t2-cmar-10-2605){ref-type="table"}). Further stratification analyses revealed the similar results in both groups, except that the number of patients with PGIN aged over 60 years was higher than that of patients with DGIN (*P*=0.001, [Table 2](#t2-cmar-10-2605){ref-type="table"}).

Identification of risk factors for GIN
======================================

To identify potential risk factors for GIN, univariate logistic regression analyses were conducted, and it was found that FCH; alcohol abuse; tobacco abuse; intake of high sodium, preserved food, spicy food, and less fruit; Hp infection; and atrophic gastritis with intestinal metaplasia were found as potential risk factors for GIN ([Table 3](#t3-cmar-10-2605){ref-type="table"}). The subgroup analyses showed that age (≥60 years) was a high risk for PGIN (OR =2.265, 95% CI: 1.455--3.524, *P*=0.001) than for DGIN (OR =1.348, 95% CI: 0.975--1.864, *P*=0.070).

Subsequently, multivariate logistic regression analyses were performed ([Table 4](#t4-cmar-10-2605){ref-type="table"}). FCH, high sodium intake, less fruit intake, Hp infection, and atrophic gastritis with intestinal metaplasia were identified as independent risk factors for GIN. Further stratification analyses confirmed that FCH, less fruit intake, Hp infection, and atrophic gastritis with intestinal metaplasia were independent risk factors for both PGIN and DGIN. One specific independent risk factor for PGIN was age, while that for DGIN was intake of high sodium.

Discussion
==========

GC is a major public health problem globally,[@b14-cmar-10-2605],[@b15-cmar-10-2605] and GIN has been well accepted as the premalignant lesion of GC.[@b3-cmar-10-2605],[@b16-cmar-10-2605] In the present study, we comprehensively explored the clinical and pathological characteristics of GIN in the Chinese population. The findings were as follows: 1) PGIN had half the number incidences of DGIN, but exhibited increasing trends during the study period, 2) age, FCH, less fruit intake, Hp infection, and atrophic gastritis with intestinal metaplasia were independent risk factors for GIN, and 3) age was a specific independent risk factor for PGIN, whereas that for DGIN was high sodium intake.

Emerging evidence indicated that GC could be divided into 2 categories, namely, PGC and DGC, due to different epidemiologic, clinicopathologic, and molecular biological characteristics.[@b9-cmar-10-2605],[@b10-cmar-10-2605],[@b17-cmar-10-2605],[@b18-cmar-10-2605] However, recent studies challenged this classification because they found that PGC was more like DGC rather than esophageal adenocarcinoma.[@b19-cmar-10-2605]--[@b21-cmar-10-2605] Considering the existing controversy about PGC and DGC, the current study was conducted to comprehensively explore the characteristics of GC's precancerous lesion, ie, GIN, and compare the difference between PGIN and DGIN. Among all 485 patients with GIN, 329 were diagnosed with DGIN and accounted for 67.8% of the population; a similar proportion of DGC was found in all GC cases.[@b13-cmar-10-2605],[@b22-cmar-10-2605] Furthermore, our results showed an increasing trend for PGIN as its proportion increased gradually during the study period 2007--2014, which was similar to the trends for PGC.[@b23-cmar-10-2605]--[@b25-cmar-10-2605]

To identify risk factors for GIN, a total of 434 GIN patients with 310 well-matched controls were recruited. Based on the results of logistic regression analyses, FCH, high sodium, less fruit intake, Hp infection, and atrophic gastritis with intestinal metaplasia were identified as independent risk factors for GIN. All abovementioned parameters except Hp infection were also well documented as the risk factors for GC, which can support the conclusion that GIN is one of the important premalignant lesions of GC to some extent.[@b26-cmar-10-2605],[@b27-cmar-10-2605] In this study, Hp infection has been identified as an independent risk factor for GIN with an OR of 2.307 (95% CI: 1.417--3.755). Although some controversies still exist, a growing body of evidence indicated that Hp infection is etiologically related to gastric cancer, and the eradication of Hp infection could contribute to a reduced incidence of GC.[@b27-cmar-10-2605],[@b28-cmar-10-2605] However, the detailed biological mechanisms underlying Hp infection-induced GIN remain far from understood. In addition, we also examined the association between anxiety/depression status and GIN risk; however, the results were negative. In a Chinese report including 118 patients with gastroesophageal precancerous lesions and 210 healthy controls, it was demonstrated that the anxiety and depression scale scores were higher in patients.[@b29-cmar-10-2605]

Considering the potential variations between PGIN and DGIN, subgroup analyses were conducted. FCH, less fruit intake, Hp infection, and atrophic gastritis with intestinal metaplasia were proven as the independent risk factors for both PGIN and DGIN. In particular, age was a specific independent risk factor for PGIN while that for DGIN was intake of high sodium. The results suggested that PGIN and DGIN shared similar etiology, similar to PGC and DGC. Further studies are warranted to validate the findings.

This study comprehensively explored the potential risk factors for Chinese GIN patients in the real-world setting and found some positive results. However, some limitations should be acknowledged in interpreting the results. First, the retrospective nature might induce selection bias, even though the study was stringently designed and conducted. Second, the limited sample size in a single institute might reduce the statistical power of the results. Third, the lost follow-up rate was relatively high (10.5%), though various efforts have been devoted and the statistical analysis showed balanced in both PGIN and DGIN groups.

Conclusion
==========

In summary, this study provided a comprehensive overview of the clinical and pathological characteristics of GIN. FCH, high sodium intake, less fruit intake, Hp infection, and atrophic gastritis were identified as the independent risk factors for GIN. Further well-designed, prospective, and unbiased studies with a larger sample size should be conducted to verify our findings.

Supplementary material
======================

###### 

Detailed items and the corresponding definitions

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **1. Baseline information**
  Name: \_\_\_\_ Age (years):\_\_\_\_ Gender:\_\_\_\_
  Operation date:\_\_\_\_ Operation name:\_\_\_\_ Physician name:\_\_\_\_
  **Pathology report 1**: by Pathologist:\_\_\_\_ Date:\_\_\_\_
  Histological type:\_\_\_\_ Size:\_\_\_\_
  Macroscopic appearance:\_\_\_\_ Location:\_\_\_\_
  **Pathology report 2**: By Pathologist:\_\_\_\_\_ Date:\_\_\_\_
  Histological type:\_\_\_\_ Size:\_\_\_\_
  Macroscopic appearance:\_\_\_\_ Location:\_\_\_\_
  *Helicobacter pylori* (Hp) infection:\_\_\_\_\_\_\_\_
  **Note:** Hp infection was determined by the rapid urease test and Giemsa stain.
  Height (cm):\_\_\_\_ Weight (kg):\_\_\_\_ Body mass index (BMI):\_\_\_\_
  **Note:** Thin: \<18.5; normal: 18.5--24.0; overweight: 24.1--28.0; obesity: \>28.0.
  **2. History of cancer**
  ➢ Personal cancer history (PCH):\_\_\_\_\_\_
  ➢ Family cancer history (FCH):\_\_\_\_\_\_\_
  **Note:** FCH includes most common malignancies such as cancers in the gastrointestinal tract, lung, prostate, and breast, etc, except skin basal cell carcinoma in patients' first- and second-degree relatives.
  **3. Personal history**
  ➢ Occupation:\_\_\_\_ History of environmental toxin exposure (ETE):\_\_\_\_\_
  **Note:** ETE was defined as a history of direct contact with toxic industrial raw materials or effluent, or living in a radius of 5 km of a heavily polluted industrious facility, or having a history of occupational toxic chemical exposure over 5 years.
  ➢ Alcohol abuse:\_\_\_\_\_\_
  **Note:** It was defined as intake of 500 mL beer, 250 mL yellow rice wine, or 50 mL wine, over twice per week.
  ➢ Tobacco abuse:\_\_\_\_\_
  **Note:** It was defined as over 10 pack/yr for tobacco abuse.
  ➢ Use of nonsteroidal anti-inflammatory drugs (NSAIDs):\_\_\_\_\_\_\_\_\_\_\_\_
  **Note:** It was defined as long-term use due to cardiovascular or rheumatoid diseases for \>6 months.
  **4. Dietary habit**
  ➢ Preferences on preserved meat (≥3 times/wk):\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
  ➢ Preferences on spicy food (≥3 times/wk):\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
  ➢ Preferences on smoked food (≥3 times/wk):\_\_\_\_\_\_\_\_\_\_\_\_
  ➢ Preferences on fried food (≥3 times/wk):\_\_\_\_\_\_\_\_\_\_\_\_\_\_
  ➢ Preferences on hot food (≥3 times/wk):\_\_\_\_\_\_\_\_\_\_\_\_
  ➢ High sodium intake (defined as over 6 g daily):\_\_\_\_\_\_\_\_\_\_\_\_\_\_
  ➢ Intake of fresh fruit and vegetables (occasional, defined as \<2/wk):\_\_\_\_
  **5. Present relevant illness**
  ➢ Gastroesophageal reflux disease (GERD):\_\_\_\_\_\_\_\_
  **Note:** GERD was defined as symptoms of acid reflux such as heartburn and laryngopharyngeal reflux.
  ➢ Hypertension (\>5 years):\_\_\_\_\_\_\_\_\_
  ➢ Diabetes mellitus (\>5 years):\_\_\_\_\_\_\_\_\_\_
  ➢ Hiatal hernia (sliding and/or mixed types):\_\_\_\_\_\_\_\_\_\_\_
  ➢ Anxiety/depression status:\_\_\_\_\_\_\_\_\_\_\_\_
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** Anxiety status was determined with Zung Self-Rating Anxiety Scale, while depression status was examined with Zung Self-Rating Depression Scale.
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![Study flow chart.\
**Notes:** A total of 485 eligible GIN patients were included in this study, among which 434 patients with detailed follow-up information were compared with 310 well-matched controls.\
**Abbreviations:** EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; GC, gastric carcinoma; GIN, gastric intraepithelial neoplasia; DGIN, distal GIN; PGIN, proximal GIN.](cmar-10-2605Fig1){#f1-cmar-10-2605}

![Overview of GIN distribution.\
**Notes:** Representative histological images of low-grade intraepithelial neoplasia **(A)**; high-grade intraepithelial neoplasia **(B)**; location distribution of GIN (**C**); and proportion of 2 GIN types (**D**). (**A**, **B**) Magnification was set at ×200.\
**Abbreviations:** GIN, gastric intraepithelial neoplasia; DGIN, distal GIN; PGIN, proximal GIN.](cmar-10-2605Fig2){#f2-cmar-10-2605}

###### 

Clinical and pathological characteristics of patients with GIN

  Variables                          GIN (n=485)   PGIN (n=156)   DGIN (n=329)   *P*-value
  ---------------------------------- ------------- -------------- -------------- -----------
  Age (years)                                                                    
   Mean ± SD                         62.3±9.2      63.8±8.5       61.6±9.4       0.018
   ≤40                               3 (0.6%)      1 (0.6%)       2 (0.6%)       0.048
   41--50                            52 (10.7%)    10 (6.4%)      42 (12.8%)     
   51--60                            147 (30.3%)   40 (25.7%)     107(32.5%)     
   61--70                            188 (38.8%)   73 (46.8%)     115 (35%)      
   ≥71                               95 (19.6%)    32 (20.5%)     63 (19.1%)     
  Gender                                                                         
   Male                              367 (75.7%)   131 (84.0%)    236 (71.7%)    0.003
   Female                            118 (24.3%)   25 (16.0%)     93 (28.3%)     
  Endoscopic morphology                                                          
   I                                 183 (37.7%)   48 (30.8%)     135 (41.0%)    0.001
   IIa                               81 (6.7%)     16 (10.3%)     65 (19.7%)     
   IIb                               72 (14.8%)    29 (18.5%)     43 (13.1%)     
   IIc                               122 (25.2%)   51 (32.7%)     71 (21.6%)     
   III                               27 (5.6%)     12 (7.7%)      15 (4.6%)      
  Lesion size (cm)                                                               
   Mean ± SD                         2.6±1.1       2.5±1.3        2.7±1.2        0.369
  Histological grade                                                             
   Low grade                         237 (48.9%)   57 (36.5%)     180 (54.7%)    \<0.001
   High grade                        248 (51.1%)   99 (63.5%)     149 (45.3%)    
  Surrounding mucosa manifestation                                               
   Chronic gastritis                 478 (98.6%)   154 (98.7%)    324 (98.5%)    0.838
   Intestinal metaplasia             434 (89.5%)   134 (85.9%)    300 (91.2%)    0.076
   Mucosal atrophy                   431 (88.9%)   133 (85.3%)    298 (90.6%)    0.082
   Hp infection                      262 (54.0%)   75 (48.1%)     187 (56.8%)    0.071
   Pancreatic metaplasia             3 (0.61%)     3 (1.3%)       0 (0%)         0.033
   Gastritis cystica profunda        33 (6.8%)     24 (15.4%)     9 (2.7%)       \<0.001

**Abbreviations:** GIN, gastric intraepithelial neoplasia; PGIN, proximal GIN; DGIN, distal GIN; Hp, *Helicobacter pylori*.

###### 

Comparison of subject characteristics between groups

  Variables                                    Control (n=310)   GIN (n=434)   PGIN (n=135)   DGIN (n=299)                           
  -------------------------------------------- ----------------- ------------- -------------- -------------- --------- ------------- ---------
  Age (years)                                                                                                                        
   Mean ± SD                                   61.25±10.80       62.02±9.03    0.308          63.07±8.45     0.167     61.77±9.28    0.526
   \<60                                        140 (45.2%)       151 (34.8%)   0.098          37 (27.4%)     0.001     114 (38.1%)   0.070
   ≥60                                         170 (54.8%)       386 (65.2%)                  98 (72.6%)               185 (61.9%)   
  Gender                                                                                                                             
   Male                                        215 (69.4%)       325 (74.9%)   0.096          103 (76.3%)    0.136     222 (74.2%)   0.180
   Female                                      95 (30.6%)        109 (25.1%)                  32 (23.7%)               77 (25.8%)    
  Hp infection                                                                                                                       
   Positive                                    93 (30.0%)        233 (53.7%)   \<0.001        61 (45.2%)     \<0.001   172 (57.5%)   0.001
   Negative                                    216 (69.7%)       201 (46.3%)                  74 (54.8%)               127 (42.5%)   
  BMI                                                                                                                                
   Average ± SD                                23.51±2.87        23.69±3.37    0.459          24.02±3.17     0.129     23.57±3.45    0.821
   BMI \<18.5                                  14 (4.5%)         18 (2.8%)     0.171          6 (4.5%)       0.561     12 (4.0%)     0.165
   18.5≤ BMI ≤24.0                             187 (60.3%)       230 (47.2%)                  72 (53.3%)               158 (52.8%)   
   24.0\< BMI ≤28.0                            97 (31.3%)        160 (36.2%)                  51 (37.8%)               109 (36.5%)   
   BMI \>28.0                                  12 (3.9%)         26 (6.7%)                    6 (4.4%)                 20 (6.7%)     
  History of cancer                                                                                                                  
   Personal                                    6 (1.9%)          8 (1.8%)      0.927          1 (0.7%)       0.352     7 (2.3%)      0.729
   Family                                      55 (17.7%)        187 (43.1%)   \<0.001        52 (38.5%)     \<0.001   135 (45.2%)   \<0.001
  Personal history                                                                                                                   
   ETE                                         51 (16.5%)        60 (13.8%)    0.321          15 (11.1%)     0.145     45 (15.1%)    0.635
   Use of NSAIDs                               18 (5.8%)         28 (6.5%)     0.719          11 (8.1%)      0.358     17 (5.7%)     0.949
   Tobacco abuse                               115 (37.1%)       247 (56.9%)   \<0.001        76 (56.3%)     \<0.001   171 (57.2%)   \<0.001
   Alcohol abuse                               114 (36.8%)       234 (53.9%)   \<0.001        72 (53.3%)     \<0.001   162 (54.2%)   \<0.001
  Dietary habit                                                                                                                      
   High sodium                                 132 (42.6%)       338 (77.9%)   \<0.001        97 (71.9%)     \<0.001   241 (80.6%)   \<0.001
   Preserved food                              83 (26.9%)        234 (53.9%)   \<0.001        67 (49.6%)     \<0.001   167 (55.9%)   \<0.001
   Spicy food                                  53 (17.1%)        173 (39.9%)   \<0.001        49 (36.3%)     0.010     124 (41.5%)   \<0.001
   Smoked food                                 8 (2.6%)          13 (3.0%)     0.690          3 (2.2%)       0.472     10 (3.3%)     0.888
   Fried food                                  14 (4.5%)         38 (8.8%)     0.259          10 (7.4%)      0.671     28 (9.4%)     0.195
   Hot food                                    74 (23.9%)        172 (39.6%)   0.106          57 (42.2%)     0.085     115 (38.5%)   0.215
   Less fruit                                  99 (31.9%)        297 (68.4%)   \<0.001        96 (71.1%)     \<0.001   201 (67.2%)   \<0.001
   Less vegetable                              45 (14.5%)        55 (12.7%)    0.467          14 (10.4%)     0.236     41 (13.7%)    0.776
  Present relevant illness                                                                                                           
   Anxiety/depression status                   68 (21.9%)        108 (24.9%)   0.133          36 (26.7%)     0.455     72 (24.1%)    0.109
   Hypertension                                62 (20.0%)        108 (24.9%)   0.118          36 (26.7%)     0.119     72 (24.0%)    0.224
   Diabetes mellitus                           22 (7.1%)         43 (9.9%)     0.181          11 (8.1%)      0.697     32 (10.7%)    0.118
   GERD                                        99 (31.9%)        120 (27.7%)   0.206          41 (30.4%)     0.215     79 (26.4%)    0.135
   Hiatal hernia                               3 (1.0%)          3 (0.7%)      0.678          2 (1.5%)       0.636     1 (0.3%)      0.333
   Columnar-lined esophagus                    2 (0.6%)          9 (2.1%)      0.111          3 (2.2%)       0.144     6 (2.0%)      0.140
   Gastric intestinal metaplasia and atrophy   112 (36.1%)       375 (86.4%)   \<0.001        122 (90.4%)    \<0.001   253 (84.6%)   \<0.001

**Abbreviations:** GIN, gastric intraepithelial neoplasia; PGIN, proximal GIN; DGIN, distal GIN; Hp, *Helicobacter pylori*; BMI, body mass index; ETE, environmental toxin exposure; NSAIDs, nonsteroidal anti-inflammatory drugs; GERD, gastroesophageal reflux disease.

###### 

Univariate analysis of risk factors for early PGIN and DGIN

  Variables                                    PGIN (n=135)             DGIN (n=299)                           
  -------------------------------------------- ------------------------ -------------- ----------------------- ---------
  Age (years)                                                                                                  
   \<60                                        1.000 (Reference)                       1.000 (Reference)       
   ≥60                                         2.265 (1.455--3.524)     0.001          1.348 (0.975--1.864)    0.070
  Gender                                                                                                       
   Female                                      1.000 (Reference)                       1.000 (Reference)       
   Male                                        1.422 (0.894--2.263)     0.137          1.274 (0.894--1.816)    0.180
   Hp infection                                3.665 (2.347--5.722)     \<0.001        2.513 (1.778--3.552)    \<0.001
  BMI                                                                                                          
   18.5≤ BMI ≤24.0                             1.000 (Reference)                       1.000 (Reference)       
   BMI \<18.5                                  1.207 (0.360--4.051)     0.760          1.172 (0.441--3.116)    0.750
   24.0\< BMI ≤28.0                            1.428 (0.920--2.217)     0.112          1.441 (1.012--2.052)    0.143
   BMI \>28.0                                  1.358 (0.490--3.764)     0.556          1.528 (1.216--5.257)    0.437
  History of cancer                                                                                            
   Personal                                    0.378 (0.045--3.171)     0.352          1.215 (0.403--3.657)    0.730
   Family                                      2.905 (1.847--4.568)     \<0.001        3.817 (2.637--5.524)    \<0.001
  Personal history                                                                                             
   ETE                                         0.635 (0.343--1.174)     0.148          0.900 (0.581--1.392)    0.635
   Use of NSAIDs                               1.439 (0.660--3.136)     0.360          0.978 (0.494--1.936)    0.949
   Tobacco abuse                               2.184 (1.448--3.294)     \<0.001        2.265(1.637--3.135)     \<0.001
   Alcohol abuse                               1.965 (1.305--2.959)     0.001          2.033 (1.470--2.811)    \<0.001
  Dietary habit                                                                                                
   High sodium                                 3.442 (2.223--5.331)     \<0.001        5.603 (3.892--8.067)    \<0.001
   Preserved food                              2.683 (1.761--4.087)     \<0.001        3.450 (2.458--4.843)    \<0.001
   Spicy food                                  1.838 (1.152--2.932)     0.011          2.286 (1.556--3.358)    \<0.001
   Smoked food                                 0.614 (0.160--2.354)     0.477          0.934 (0.363--2.407)    0.888
   Fried food                                  1.200 (0.517--2.783)     0.671          1.550 (0.796--3.018)    0.198
   Hot food                                    1.471 (0.947--2.287)     0.086          1.258 (0.875--1.810)    0.215
   Less fruit                                  5.246 (3.371--8.164)     \<0.001        4.000 (2.860--5.593)    \<0.001
   Less vegetable                              0.681 (0.360--1.289)     0.238          0.936 (0.593--1.477)    0.776
  Present relevant illness                                                                                     
   Anxiety/depression status                   0.834 (0.518--1.343)     0.456          0.728 (0.493--1.074)    0.109
   Hypertension                                1.431 (0.82--2.54)       0.119          1.242 (0.78--1.51)      0.224
   Diabetes mellitus                           1.161 (0.546--2.468)     0.697          1.569 (0.889--2.768)    0.120
   GERD                                        0.771 (0.500--1.190)     0.215          0.765 (0.539--1.087)    0.135
   Hiatal hernia                               1.539 (0.254--9.316)     0.639          0.343 (0.036--3.320)    0.356
   Columnar-lined esophagus                    3.527 (0.582--21.353)    0.170          3.154 (0.631--15.750)   0.162
   Gastric intestinal metaplasia and atrophy   16.591 (8.952--30.748)   \<0.001        9.723 (6.581--14.366)   \<0.001

**Abbreviations:** PGIN, proximal gastric intraepithelial neoplasia; DGIN, distal gastric intraepithelial neoplasia; OR, odds ratio; 95% CI, 95% confidential interval; Hp, *Helicobacter pylori*; BMI, body mass index; ETE, environmental toxin exposure; NSAIDs, nonsteroidal anti-inflammatory drugs; GERD, gastroesophageal reflux disease.

###### 

Multivariate analysis of risk factors for PGIN and DGIN

  Variables                                    GIN (n=434)              PGIN (n=135)   DGIN (n=299)                                                
  -------------------------------------------- ------------------------ -------------- ------------------------ --------- ------------------------ ---------
  Age (years)                                                                                                                                      
   \<60                                        1.000 (Reference)                       1.000 (Reference)                  1.000 (Reference)        
   ≥60                                         0.845 (0.623--1.254)     0.087          2.001 (1.003--3.994)     0.049     1.511 (0.895--2.549)     0.122
  Hp infection                                 2.307 (1.417--3.755)     0.001          2.057 (1.601--5.838)     0.003     2.553 (1.393--4.681)     0.002
  Family history of cancer                     3.485 (2.031--5.981)     \<0.001        3.089 (1.515--6.300)     0.002     3.802 (2.118--6.825)     \<0.001
  Personal history                                                                                                                                 
   Tobacco abuse                               1.561 (0.883--2.759)     0.126          1.840 (0.850--3.987)     0.122     1.389 (0.754--2.558)     0.292
   Alcohol abuse                               0.896 (0.500--1.603)     0.711          0.872 (0.396--1.923)     0.735     0.937 (0.502--1.748)     0.838
  Dietary habit                                                                                                                                    
   High sodium                                 2.830 (1.645--4.868)     \<0.001        1.840 (0.850--3.987)     0.257     3.467 (1.896--6.338)     \<0.001
   Preserved food                              1.520 (0.894--2.584)     0.120          1.758 (0.860--3.595)     0.123     1.393 (0.783--2.479)     0.259
   Spicy food                                  1.309 (0.752--2.280)     0.341          1.325 (0.612--2.872)     0.475     1.487 (0.812--2.722)     0.199
   Less fruit                                  4.082 (2.515--6.625)     \<0.001        4.752 (2.469--9.145)     \<0.001   3.678 (2.173--6.225)     \<0.001
  Present relevant illness                                                                                                                         
   Gastric intestinal metaplasia and atrophy   15.070 (8.999--25.237)   \<0.001        16.423 (7.513--35.898)   \<0.001   14.337 (8.102--25.371)   \<0.001

**Abbreviations:** GIN, gastric intraepithelial neoplasia; PGIN, proximal GIN; DGIN, distal GIN; OR, odds ratio; 95% CI, 95% confidential interval; Hp, *Helicobacter pylori*.
